Mattson expands to Chicago with acquisition of Hyde Park Group, explores the Ozempic effect
GLP-1 drugs are “going to be a big disruptor for the food industry,” says Dr. Justin Shimek at California-based product innovation firm Mattson, which is expanding to the Midwest with the acquisition of Hyde Park Group.
Sponsored
International Fresh Produce Association launches year 3 of its produce accelerator